E. J. Cook

发表

Maternal serum alpha-fetoprotein (MSAFP) patient-specific risk reporting: its use and misuse.

D. Krantz, R. Kasturi, J. Macri, 1990, American journal of human genetics.

Free β-Chorionic Gonadotropin: A Cross-Reactivity Study of Two Immunometric Assays Used in Prenatal Maternal Serum Screening for Down's Syndrome

K. Spencer, J. Macri, E. J. Cook, 1993 .

Maternal serum Down syndrome screening: free beta-protein is a more effective marker than human chorionic gonadotropin.

D. Krantz, J. Young, R. Kasturi, 1990, American journal of obstetrics and gynecology.

Maternal serum Down syndrome screening: unconjugated estriol is not useful.

S. Sunderji, D. Krantz, R. Kasturi, 1990, American journal of obstetrics and gynecology.

Free beta-chorionic gonadotropin: a cross-reactivity study of two immunometric assays used in prenatal maternal serum screening for Down's syndrome.

K. Spencer, J. Macri, E. J. Cook, 1993, Annals of clinical biochemistry.

Measurement of unconjugated estriol by enzyme-linked immunosorbent assay fails to show an association with Down syndrome.

D. Krantz, R. Kasturi, J. Larsen, 1990, American journal of obstetrics and gynecology.

Maternal serum α-fetoprotein screening

P. Sajda, D. Krantz, R. Kasturi, 1987 .

Maternal serum alpha-fetoprotein screening. III. Pitfalls in evaluating black gravid women.

P. Sajda, D. Krantz, R. Kasturi, 1987, American journal of obstetrics and gynecology.

Sensitivity and specificity of screening for Down syndrome with alpha-fetoprotein, hCG, unconjugated estriol, and maternal age.

D. Krantz, R. Kasturi, J. Macri, 1991, Obstetrics and Gynecology.

Variability in MSAFP predicted rates of Down syndrome.

D. Krantz, R. Kasturi, J. Macri, 1989, American journal of human genetics.